Texas Yale Capital Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$698K Hold
9,990
0.02% 294
2025
Q1
$734K Sell
9,990
-4,100
-29% -$301K 0.03% 290
2024
Q4
$923K Buy
14,090
+612
+5% +$40.1K 0.04% 259
2024
Q3
$1.05M Buy
13,478
+300
+2% +$23.4K 0.05% 258
2024
Q2
$1.03M Hold
13,178
0.05% 246
2024
Q1
$893K Buy
13,178
+376
+3% +$25.5K 0.04% 267
2023
Q4
$862K Buy
12,802
+157
+1% +$10.6K 0.04% 267
2023
Q3
$856K Sell
12,645
-1,480
-10% -$100K 0.04% 247
2023
Q2
$1.01M Hold
14,125
0.05% 247
2023
Q1
$980K Hold
14,125
0.05% 250
2022
Q4
$958K Hold
14,125
0.05% 246
2022
Q3
$775K Buy
14,125
+1,010
+8% +$55.4K 0.05% 262
2022
Q2
$867K Hold
13,115
0.06% 247
2022
Q1
$870K Hold
13,115
0.05% 259
2021
Q4
$764K Hold
13,115
0.04% 277
2021
Q3
$788K Hold
13,115
0.04% 265
2021
Q2
$786K Hold
13,115
0.04% 267
2021
Q1
$652K Sell
13,115
-4,400
-25% -$219K 0.04% 282
2020
Q4
$876K Buy
17,515
+200
+1% +$10K 0.06% 248
2020
Q3
$949K Buy
17,315
+100
+0.6% +$5.48K 0.07% 225
2020
Q2
$911K Hold
17,215
0.07% 221
2020
Q1
$769K Hold
17,215
0.08% 226
2019
Q4
$858K Hold
17,215
0.06% 263
2019
Q3
$767K Hold
17,215
0.06% 270
2019
Q2
$711K Sell
17,215
-17,215
-50% -$711K 0.05% 283
2019
Q1
$1.39M Buy
34,430
+17,215
+100% +$696K 0.06% 276
2018
Q4
$654K Hold
17,215
0.06% 260
2018
Q3
$681K Hold
17,215
0.06% 286
2018
Q2
$604K Hold
17,215
0.05% 296
2018
Q1
$602K Sell
17,215
-365
-2% -$12.8K 0.05% 290
2017
Q4
$610K Buy
17,580
+4,580
+35% +$159K 0.05% 293
2017
Q3
$440K Hold
13,000
0.04% 335
2017
Q2
$443K Hold
13,000
0.04% 332
2017
Q1
$405K Buy
13,000
+1,500
+13% +$46.7K 0.04% 335
2016
Q4
$314K Sell
11,500
-457
-4% -$12.5K 0.03% 362
2016
Q3
$393K Hold
11,957
0.04% 343
2016
Q2
$361K Hold
11,957
0.04% 351
2016
Q1
$337K Hold
11,957
0.03% 352
2015
Q4
$406K Buy
11,957
+457
+4% +$15.5K 0.04% 329
2015
Q3
$366K Hold
11,500
0.03% 351
2015
Q2
$366K Hold
11,500
0.03% 382
2015
Q1
$393K Buy
11,500
+490
+4% +$16.7K 0.03% 378
2014
Q4
$387K Hold
11,010
0.03% 364
2014
Q3
$393K Buy
+11,010
New +$393K 0.04% 333